Alcon Inc. has updated its full-year revenue forecast to between $10.4 billion and $10.5 billion after acquiring a majority stake in Aurion Biotech. The company anticipates sales growth of 6% to 7% in constant currency, with profitability impacted by increased R&D spending and integration costs. Stronger product launches are expected in the second half of 2025.

Centurion Corporation is moving forward with plans to establish a real estate investment trust (REIT), leveraging its $2.5 billion in assets and expanded bed capacity. The company reported a 97% jump in half-year net profit, driven by strong construction demand and asset revaluation, and aims to become more asset-light through the REIT initiative.

United States Antimony posted a 128% year-over-year increase in Q1 2025 revenue, reaching $7 million. Despite strong growth in sales and net income, shares fell over 7% in aftermarket trading due to a slight revenue miss. The company tightened its annual guidance and outlined expansion plans in Alaska and Montana.